Exhibit 99.1
MorphoSys AG Annual General Meeting on 19.05.2021 | ||
Voting Results |
TOP | Index | Number of valid votes | in % of registered capital stock | Yes-Votes | Yes-% | No-Votes | No-% | |||||||||||||||||||||
2 | Resolution on the discharge of Management Board members for the 2020 financial year | 19,748,968 | 60.05 | 19,623,835 | 99.37 | 125,133 | 0.63 | |||||||||||||||||||||
3 | Resolution on the discharge of Supervisory Board members for the 2020 financial year | 19,755,088 | 60.06 | 19,609,447 | 99.26 | 145,641 | 0.74 | |||||||||||||||||||||
4 | Resolution on the appointment of the auditor for the 2021 financial year | 20,373,637 | 61.94 | 20,335,168 | 99.81 | 38,469 | 0.19 | |||||||||||||||||||||
5 | Resolution on the election of Supervisory Board members: | |||||||||||||||||||||||||||
a) | Dr. Marc Cluzel | 20,371,998 | 61.94 | 19,171,653 | 94.11 | 1,200,345 | 5.89 | |||||||||||||||||||||
b) | Ms. Krisja Vermeylen | 20,372,439 | 61.94 | 19,158,408 | 94.04 | 1,214,031 | 5.96 | |||||||||||||||||||||
c) | Ms. Sharon Curran | 20,372,305 | 61.94 | 20,263,772 | 99.47 | 108,533 | 0.53 | |||||||||||||||||||||
6 | Resolution on the cancellation of Authorized Capital 2018-I and the creation of a new Authorized Capital 2021-I with the option to exclude statutory subscription rights; amendment to the Articles of Association | 20,103,845 | 61.12 | 18,945,409 | 94.24 | 1,158,436 | 5.76 | |||||||||||||||||||||
7 | Resolution on the cancellation of Authorized Capital 2020-I and the creation of a new Authorized Capital 2021-II with the option to exclude statutory subscription rights; amendment to the Articles of Association | 20,103,689 | 61.12 | 18,969,979 | 94.36 | 1,133,710 | 5.64 |
MorphoSys AG Annual General Meeting on 19.05.2021 | ||
Voting Results |
TOP | Index | Number of valid votes | in % of registered capital stock | Yes-Votes | Yes-% | No-Votes | No-% | |||||||||||||||||||||
8 | Resolution on the creation of an Authorized Capital 2021-III under exclusion of subscription rights for the purpose of serving “Restricted Stock Units” to be issued to senior managers and employees of MorphoSys US Inc. under the “Restricted Stock Unit Program 2021” of the Company; amendment to the Articles of Association | 19,771,843 | 60.11 | 18,054,818 | 91.32 | 1,717,025 | 8.68 | |||||||||||||||||||||
9 | Resolution on the cancellation of Conditional Capital 2008-III, the reduction of Conditional Capital 2016-I and the reduction of Conditional Capital 2016-III; amendments to the Articles of Association | 20,370,948 | 61.94 | 20,317,647 | 99.74 | 53,301 | 0.26 | |||||||||||||||||||||
10 | Resolution on the creation of a new Conditional Capital 2021-I and the authorization of the Management Board to issue convertible bonds/bonds with warrants with the option to exclude subscription rights; amendment to the Articles of Association | 19,503,402 | 59.30 | 18,335,515 | 94.01 | 1,167,887 | 5.99 | |||||||||||||||||||||
11 | Resolution on the approval of the remuneration system for members of the Management Board | 19,176,424 | 58.30 | 6,938,977 | 36.18 | 12,237,447 | 63.82 | |||||||||||||||||||||
12 | Resolution on the remuneration of the members of the Supervisory Board | 19,745,052 | 60.03 | 19,632,464 | 99.43 | 112,588 | 0.57 | |||||||||||||||||||||
13 | Resolution on further amendments to the Articles of Association | 20,369,723 | 61.93 | 20,286,748 | 99.59 | 82,975 | 0.41 |